​

Psilocybin is a topic in the health domain with significant developments in policy, regulation, and public health impact.

Key developments include uk's first publicly funded trial shows psilocybin significantly improves treatment-resistant depression, trump signs executive order to expedite psychedelic drug review and reclassification, compass pathways' psilocybin therapy shows durable benefits for treatment-resistant depression in pivotal trial, among other significant events and policy changes.

Source: Geo Health Space